NO180167C - Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol - Google Patents

Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Info

Publication number
NO180167C
NO180167C NO943327A NO943327A NO180167C NO 180167 C NO180167 C NO 180167C NO 943327 A NO943327 A NO 943327A NO 943327 A NO943327 A NO 943327A NO 180167 C NO180167 C NO 180167C
Authority
NO
Norway
Prior art keywords
cells
cytosol
introducing molecules
photochemical method
photodynamic treatment
Prior art date
Application number
NO943327A
Other languages
English (en)
Norwegian (no)
Other versions
NO943327D0 (no
NO943327L (no
NO180167B (no
Inventor
Kristian Berg
Johan Moan
Kirsten Sandvig
Original Assignee
Photocure As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure As filed Critical Photocure As
Priority to NO943327A priority Critical patent/NO180167C/no
Publication of NO943327D0 publication Critical patent/NO943327D0/no
Priority to EP95932244A priority patent/EP0783323B1/en
Priority to CA2199290A priority patent/CA2199290C/en
Priority to MX9701676A priority patent/MX9701676A/es
Priority to AU35347/95A priority patent/AU700797B2/en
Priority to CNB951960652A priority patent/CN1222309C/zh
Priority to DE69524238T priority patent/DE69524238T2/de
Priority to AT95932244T priority patent/ATE209507T1/de
Priority to NZ293008A priority patent/NZ293008A/en
Priority to ES95932244T priority patent/ES2163527T3/es
Priority to HK98103468.0A priority patent/HK1004110B/xx
Priority to CZ97658A priority patent/CZ65897A3/cs
Priority to PT95932244T priority patent/PT783323E/pt
Priority to PCT/NO1995/000149 priority patent/WO1996007432A1/en
Priority to US08/793,794 priority patent/US5876989A/en
Priority to BRPI9508825A priority patent/BRPI9508825B8/pt
Priority to JP50940496A priority patent/JP4148328B2/ja
Priority to HU9800153A priority patent/HU222984B1/hu
Priority to NZ509519A priority patent/NZ509519A/en
Priority to KR1019970701520A priority patent/KR100395615B1/ko
Priority to KR10-2003-7005142A priority patent/KR100529967B1/ko
Publication of NO943327L publication Critical patent/NO943327L/no
Publication of NO180167B publication Critical patent/NO180167B/no
Publication of NO180167C publication Critical patent/NO180167C/no
Priority to FI970983A priority patent/FI121328B/fi
Priority to US09/144,750 priority patent/US6680301B2/en
Priority to US10/286,632 priority patent/US20030134813A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Catalysts (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO943327A 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol NO180167C (no)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
NZ509519A NZ509519A (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
PT95932244T PT783323E (pt) 1994-09-08 1995-09-04 Transferencia de moleculas para o citosol de celulas por meio de compostos fotossensibilizantes
US08/793,794 US5876989A (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
MX9701676A MX9701676A (es) 1994-09-08 1995-09-04 Transferencia de moleculas al citosol de celulas.
AU35347/95A AU700797B2 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
CNB951960652A CN1222309C (zh) 1994-09-08 1995-09-04 将分子导入细胞溶质
DE69524238T DE69524238T2 (de) 1994-09-08 1995-09-04 Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen
AT95932244T ATE209507T1 (de) 1994-09-08 1995-09-04 Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen
NZ293008A NZ293008A (en) 1994-09-08 1995-09-04 Photoactivatable compound-carrier molecule conjugates for transfer into a cell cytosol where they are taken up by endosomes and lysosomes
ES95932244T ES2163527T3 (es) 1994-09-08 1995-09-04 Transferencia de moleculas hacia el interior del citosol de las celulas por medio de sustancias fotosensibilizadoras.
HK98103468.0A HK1004110B (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
CZ97658A CZ65897A3 (en) 1994-09-08 1995-09-04 Method of transferring molecules into cytosol of cells, set for making the method and a mixture for modification neoplastic or other cellular processes
EP95932244A EP0783323B1 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells by photosensitizing compounds
PCT/NO1995/000149 WO1996007432A1 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
CA2199290A CA2199290C (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
BRPI9508825A BRPI9508825B8 (pt) 1994-09-08 1995-09-04 processo de transferência de moléculas para o citosol de células, composição e kit
JP50940496A JP4148328B2 (ja) 1994-09-08 1995-09-04 細胞サイトゾルへの化合物の移入
HU9800153A HU222984B1 (hu) 1994-09-08 1995-09-04 Eljárás molekulák in vitro bevezetésére élő sejtek citoszoljába, fotoszenzibilizáló vegyület alkalmazásával
KR10-2003-7005142A KR100529967B1 (ko) 1994-09-08 1995-09-14 세포의 시토졸내로 분자를 전달시키는 조성물
KR1019970701520A KR100395615B1 (ko) 1994-09-08 1995-09-14 세포의시토졸내로분자를전달시키는방법
FI970983A FI121328B (fi) 1994-09-08 1997-03-07 Molekyylien siirto solujen sytosoliin
US09/144,750 US6680301B2 (en) 1994-09-08 1998-09-01 Transfer of molecules into the cytosol of cells
US10/286,632 US20030134813A1 (en) 1994-09-08 2002-11-01 Transfer of molecules into the cytosol of cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Publications (4)

Publication Number Publication Date
NO943327D0 NO943327D0 (no) 1994-09-08
NO943327L NO943327L (no) 1996-03-11
NO180167B NO180167B (no) 1996-11-18
NO180167C true NO180167C (no) 1997-02-26

Family

ID=19897382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Country Status (19)

Country Link
US (3) US5876989A (cs)
EP (1) EP0783323B1 (cs)
JP (1) JP4148328B2 (cs)
KR (2) KR100395615B1 (cs)
CN (1) CN1222309C (cs)
AT (1) ATE209507T1 (cs)
AU (1) AU700797B2 (cs)
BR (1) BRPI9508825B8 (cs)
CA (1) CA2199290C (cs)
CZ (1) CZ65897A3 (cs)
DE (1) DE69524238T2 (cs)
ES (1) ES2163527T3 (cs)
FI (1) FI121328B (cs)
HU (1) HU222984B1 (cs)
MX (1) MX9701676A (cs)
NO (1) NO180167C (cs)
NZ (2) NZ509519A (cs)
PT (1) PT783323E (cs)
WO (1) WO1996007432A1 (cs)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US5995867A (en) * 1997-03-19 1999-11-30 Lucid Inc Cellular surgery utilizing confocal microscopy
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
EP2138191A1 (en) 1998-01-05 2009-12-30 University Of Washington Enhanced transport using membrane disruptive agents
US6399769B1 (en) * 1998-01-20 2002-06-04 Kimberly-Clark Worldwide, Inc. Method of making sulfanatophenyl substituted porphines
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
US7320885B1 (en) * 1999-09-09 2008-01-22 Toudai Tlo, Ltd. Method of perforating membrane and apparatus therefor
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
JP5610659B2 (ja) * 2000-07-21 2014-10-22 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 多成分生物学的輸送システム
HU229805B1 (en) * 2000-11-29 2014-07-28 Pci Biotech As Photochemical internalization for delivery of molecules into the cytosol
EP1339862B1 (en) * 2000-11-29 2014-01-08 PCI Biotech AS Photochemical internalization for virus-mediated molecule delivery into the cytosol
US20020098472A1 (en) * 2000-11-30 2002-07-25 Erlach Julian Van Method for inserting a microdevice or a nanodevice into a body fluid stream
US20020137901A1 (en) * 2001-01-22 2002-09-26 Cavanaugh Philip Gerard Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
WO2002062989A2 (en) * 2001-02-08 2002-08-15 Sequitur, Inc. Methods of light activated release 0f ligands from endosomes
ATE429930T1 (de) * 2001-06-20 2009-05-15 Dainippon Sumitomo Pharma Co Verfahren zur förderung des nukleinsäuretransfers
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
AU2002359576A1 (en) 2001-12-03 2003-06-17 Ekos Corporation Catheter with multiple ultrasound radiating members
US7141044B2 (en) 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
US20060009409A1 (en) 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
WO2003064621A2 (en) * 2002-02-01 2003-08-07 Ambion, Inc. HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
EP3415625A1 (en) 2002-02-01 2018-12-19 Life Technologies Corporation Double-stranded oligonucleotides
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
GB0215534D0 (en) * 2002-07-04 2002-08-14 Ecole Polytech Selective photochemotherapy using oligonucleotide targeting agents
US20040029275A1 (en) * 2002-08-10 2004-02-12 David Brown Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
WO2004063342A2 (en) * 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
DE602004026747D1 (de) * 2003-09-29 2010-06-02 Nitto Denko Corp Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
EP1696034A4 (en) * 2003-12-19 2006-12-27 Dainippon Sumitomo Pharma Co NUCLEIC ACID TRANSFER METHOD
SG150570A1 (en) * 2004-03-03 2009-03-30 Revance Therapeutics Inc Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
CA2558408C (en) 2004-03-03 2014-11-18 Essentia Biosystems, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
GB0415263D0 (en) * 2004-07-07 2004-08-11 Norwegian Radium Hospital Res Method
US20060094781A1 (en) * 2004-11-04 2006-05-04 Syneron Medical Ltd. Method of treating extracellular matrix
FR2877943B1 (fr) * 2004-11-16 2008-09-05 Univ De Coimbra Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique
SG160358A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of an oligopeptide
WO2006094263A2 (en) 2005-03-03 2006-09-08 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US7674452B2 (en) * 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
BRPI0501037B8 (pt) 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
NZ568216A (en) * 2005-11-17 2012-09-28 Revance Therapeutics Inc Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
WO2007109584A1 (en) * 2006-03-16 2007-09-27 University Of Washington Temperature-and ph-responsive polymer compositions
GB0613753D0 (en) 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
WO2008073856A2 (en) * 2006-12-08 2008-06-19 Massachusetts Institute Of Technology Delivery of nanoparticles and/or agents to cells
AU2007340162B2 (en) * 2006-12-29 2013-08-01 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from HIV-TAT
WO2008082885A2 (en) * 2006-12-29 2008-07-10 Revance Therapeutics, Inc. Transport molecules using reverse sequence hiv-tat polypeptides
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
WO2009002881A1 (en) 2007-06-22 2008-12-31 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US20090187137A1 (en) * 2007-12-14 2009-07-23 Kim Volz Ultrasound pulse shaping
GB0811955D0 (en) 2008-06-30 2008-07-30 Pci Biotech As Method
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
GB0914286D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Method
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
GB201208548D0 (en) * 2012-05-15 2012-06-27 Pci Biotech As Compound and method
US20160040128A1 (en) 2013-03-15 2016-02-11 Pci Biotech As Method
GB2517707B (en) 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
AU2014314149B2 (en) 2013-08-28 2019-12-19 Pci Biotech As Compound and method for vaccination and immunisation
AU2014390262B2 (en) 2014-04-11 2020-11-26 Pci Biotech As Method of treating melanoma
CN108136016A (zh) 2014-08-28 2018-06-08 Pci生物技术公司 化合物和方法
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
EP3307388B1 (en) 2015-06-10 2022-06-22 Ekos Corporation Ultrasound catheter
RU2019109682A (ru) 2016-10-14 2020-11-16 ПиСиАй БИОТЕК АС Лечение холангиокарциномы с применением tpcs-2-индуцированной фотохимической интернализации гемцитабина
GB201718631D0 (en) 2017-11-10 2017-12-27 Pci Biotech As Method
GB201801169D0 (en) * 2018-01-24 2018-03-07 Pci Biotech As Method
EP3823668A1 (en) 2018-07-16 2021-05-26 DCPrime B.V. A combination product for use in tumor vaccination
WO2020217226A1 (en) 2019-04-25 2020-10-29 Dcprime B.V. Methods of tumor vaccination
CN110711249B (zh) * 2019-09-19 2020-10-27 北京化工大学 一种溶酶体膜包覆纳米颗粒的制备方法
US20210322471A1 (en) 2020-03-27 2021-10-21 Dcprime B.V. In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
WO2021191870A1 (en) 2020-03-27 2021-09-30 Dcprime B.V. Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
KR20230033647A (ko) 2020-06-30 2023-03-08 멘두스 비.브이. 난소암 백신에서 백혈병 유래 세포의 용도
CN114163508B (zh) * 2020-09-11 2024-07-16 王月志 能破坏细胞的氨基酸序列及相关核苷酸序列和相关的应用
WO2022097068A1 (en) 2020-11-05 2022-05-12 Dcprime B.V. Use of tumor-independent antigens in immunotherapies
AU2022211682A1 (en) 2021-01-22 2023-08-03 Mendus B.V. Methods of tumor vaccination
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
WO2022190058A1 (en) 2021-03-12 2022-09-15 Dcprime B.V. Methods of vaccination and use of cd47 blockade
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
WO2024068795A1 (en) 2022-09-27 2024-04-04 Pci Biotech As Method for releasing viral vectors
GB202301312D0 (en) 2023-01-30 2023-03-15 Pci Biotech As Method and product
GB202404168D0 (en) 2024-03-22 2024-05-08 Pci Biotech As Method

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
HU204856B (en) 1987-08-12 1992-02-28 Orszagos Mueszaki Fejlesztesi Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates
NO891491L (no) * 1987-08-12 1989-04-11 Peter Nemeth Prosedyre for befrielse av celleblandinger og vev for uoenskede populasjoner.
GB8721108D0 (en) * 1987-09-08 1987-10-14 Salford University Of Liposomes
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5567687A (en) * 1989-03-06 1996-10-22 University Of Texas Texaphyrins and uses thereof
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5258453A (en) * 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
ATE212063T1 (de) * 1992-03-16 2002-02-15 Isis Pharmaceuticals Inc Oligonukleotide modulation von protein kinase c
DE69301725T2 (de) 1992-03-20 1996-07-25 Celsis Int Plc Verfahren und gerät zur analyse von biologischem material
AU4115693A (en) * 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
WO1994007138A1 (en) 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
ZA938208B (en) * 1992-11-03 1995-01-03 Gene Shears Pty Ltd TNF-alpha ribozymes and degradation resistant mRNA derivatives linked to TNF-alpha ribozymes
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US6015897A (en) * 1993-12-07 2000-01-18 Neorx Corporation Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO180167C (no) 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5872007A (en) * 1995-02-17 1999-02-16 Hybridon, Inc. CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer

Also Published As

Publication number Publication date
CA2199290C (en) 2010-10-26
NO943327D0 (no) 1994-09-08
AU700797B2 (en) 1999-01-14
US20020155099A1 (en) 2002-10-24
NO943327L (no) 1996-03-11
JPH10508295A (ja) 1998-08-18
US20030134813A1 (en) 2003-07-17
JP4148328B2 (ja) 2008-09-10
DE69524238D1 (de) 2002-01-10
AU3534795A (en) 1996-03-27
CA2199290A1 (en) 1996-03-14
CN1222309C (zh) 2005-10-12
FI121328B (fi) 2010-10-15
EP0783323A1 (en) 1997-07-16
BR9508825A (pt) 1998-01-06
PT783323E (pt) 2002-03-28
CZ65897A3 (en) 1997-10-15
EP0783323B1 (en) 2001-11-28
ATE209507T1 (de) 2001-12-15
MX9701676A (es) 1998-04-30
FI970983A0 (fi) 1997-03-07
WO1996007432A1 (en) 1996-03-14
HU222984B1 (hu) 2004-01-28
FI970983L (fi) 1997-03-07
NZ509519A (en) 2004-10-29
HK1004110A1 (en) 1998-11-20
ES2163527T3 (es) 2002-02-01
CN1164829A (zh) 1997-11-12
DE69524238T2 (de) 2002-07-18
KR970705415A (ko) 1997-10-09
US6680301B2 (en) 2004-01-20
BRPI9508825B1 (pt) 2020-12-22
NO180167B (no) 1996-11-18
US5876989A (en) 1999-03-02
NZ293008A (en) 2001-04-27
KR100529967B1 (ko) 2005-11-22
BRPI9508825B8 (pt) 2021-07-06
HUT77469A (hu) 1998-05-28
KR100395615B1 (ko) 2003-12-31
KR20040004402A (ko) 2004-01-13

Similar Documents

Publication Publication Date Title
NO943327L (no) Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
EP0883344A4 (en) THERAPEUTIC MOLECULES OBTAINED BY TRANS-SPLITTING
WO2002036743A3 (en) Antisense modulation of calreticulin expression
AU5753598A (en) Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use
CA2394984A1 (en) Novel plant expression constructs
DK0923592T3 (da) Fremgangsmåder til rensning af nukleinsyrer
EP2199299A3 (en) Antisense modulation of survivin expression
WO2003011887A3 (en) Antisense modulation of apolipoprotein b expression
WO2003014307A3 (en) Antisense modulation of apolipoprotein(a) expression
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
AR023482A1 (es) Acidos nucleicos que codifican polipeptidos quimericos cd40/cd4ol, metodos para su produccion y usos de los mismos
WO2001029175A3 (en) Antisense modulation of fra-1 expression
AU2672099A (en) Compositions and methods for wound healing
ATE402257T1 (de) Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit
WO2002050248A3 (en) Antisense modulation of hepsin expression
WO2002050244A3 (en) Antisense modulation of histone deacetylase 1 expression
GEP19991780B (en) Use of Pyrrolidine Derivatives for Treating Alcoholism
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
IL131436A0 (en) Compositions for treatment of disorders involving programmed cell death
BR0010396A (pt) Composições e métodos para a modificação da expressão de genes
WO2003040161A3 (en) Antisense modulation of activating transcription factor 3 expression
DE69733948D1 (de) In vivo herstellung von replicativen molekülen

Legal Events

Date Code Title Description
MK1K Patent expired